493 related articles for article (PubMed ID: 27824965)
1. Hashimoto's thyroiditis and papillary thyroid carcinoma. Are cytokeratin 19 and P63 proteins of any diagnostic value?
Divani SN; Kalodimos GP; Lioupis MA; Syrmos NC
Hell J Nucl Med; 2016; 19(3):250-253. PubMed ID: 27824965
[TBL] [Abstract][Full Text] [Related]
2. High TPOAb Levels (>1300 IU/mL) Indicate Multifocal PTC in Hashimoto's Thyroiditis Patients and Support Total Thyroidectomy.
Dong S; Xia Q; Wu YJ
Otolaryngol Head Neck Surg; 2015 Jul; 153(1):20-6. PubMed ID: 25917667
[TBL] [Abstract][Full Text] [Related]
3. Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis.
Lun Y; Wu X; Xia Q; Han Y; Zhang X; Liu Z; Wang F; Duan Z; Xin S; Zhang J
Otolaryngol Head Neck Surg; 2013 Mar; 148(3):396-402. PubMed ID: 23300224
[TBL] [Abstract][Full Text] [Related]
4. The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease.
Zhang L; Li H; Ji QH; Zhu YX; Wang ZY; Wang Y; Huang CP; Shen Q; Li DS; Wu Y
BMC Cancer; 2012 Dec; 12():610. PubMed ID: 23256514
[TBL] [Abstract][Full Text] [Related]
5. IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent/recurrent disease in papillary thyroid carcinoma with/without Hashimoto's thyroiditis.
Stanciu AE; Serdarevic N; Hurduc AE; Stanciu MM
Scand J Clin Lab Invest; 2015 Nov; 75(7):539-48. PubMed ID: 26305420
[TBL] [Abstract][Full Text] [Related]
6. Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto's thyroiditis.
Kim KW; Park YJ; Kim EH; Park SY; Park DJ; Ahn SH; Park DJ; Jang HC; Cho BY
Head Neck; 2011 May; 33(5):691-5. PubMed ID: 21484918
[TBL] [Abstract][Full Text] [Related]
7. Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDG-PET: prevalence of thyroid cancer and Hashimoto's thyroiditis.
Kurata S; Ishibashi M; Hiromatsu Y; Kaida H; Miyake I; Uchida M; Hayabuchi N
Ann Nucl Med; 2007 Aug; 21(6):325-30. PubMed ID: 17705011
[TBL] [Abstract][Full Text] [Related]
8. Co-occurrence of papillary thyroid carcinoma and primary lymphoma of the thyroid in a patient with long-standing Hashimoto's thyroiditis.
Cheng V; Brainard J; Nasr C
Thyroid; 2012 Jun; 22(6):647-50. PubMed ID: 22568399
[TBL] [Abstract][Full Text] [Related]
9. Hashimoto's Thyroiditis Does Not Affect Ultrasonographical, Cytological, and Histopathological Features in Patients with Papillary Thyroid Carcinoma.
Baser H; Ozdemir D; Cuhaci N; Aydin C; Ersoy R; Kilicarslan A; Cakir B
Endocr Pathol; 2015 Dec; 26(4):356-64. PubMed ID: 26481630
[TBL] [Abstract][Full Text] [Related]
10. Impact of Hashimoto's thyroiditis, TSH levels, and anti-thyroid antibody positivity on differentiated thyroid carcinoma incidence.
Gabalec F; Srbova L; Nova M; Hovorkova E; Hornychova H; Jakubikova I; Ryska A; Cap J
Endokrynol Pol; 2016; 67(1):48-53. PubMed ID: 26884115
[TBL] [Abstract][Full Text] [Related]
11. Warthin-like papillary thyroid carcinoma with immunoglobulin G4-positive plasma cells possibly related to Hashimoto's thyroiditis.
Hirokawa M; Nishihara E; Takada N; Higuchi M; Kotakemori M; Hayashi T; Miyauchi A
Endocr J; 2018 Feb; 65(2):175-180. PubMed ID: 29093307
[TBL] [Abstract][Full Text] [Related]
12. Combined effect of Hashimoto's thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancer.
Kim SJ; Myong JP; Jee HG; Chai YJ; Choi JY; Min HS; Lee KE; Youn YK
Head Neck; 2016 Jan; 38(1):95-101. PubMed ID: 25213729
[TBL] [Abstract][Full Text] [Related]
13. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.
Vasileiadis I; Boutzios G; Charitoudis G; Koukoulioti E; Karatzas T
Ann Surg Oncol; 2014 Aug; 21(8):2725-32. PubMed ID: 24595799
[TBL] [Abstract][Full Text] [Related]
14. Clinical Relationship Between IgG4-Positive Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma.
Yu Y; Zhang J; Lu G; Li T; Zhang Y; Yu N; Gao Y; Gao Y; Guo X
J Clin Endocrinol Metab; 2016 Apr; 101(4):1516-24. PubMed ID: 26866571
[TBL] [Abstract][Full Text] [Related]
15. Expression of papillary thyroid carcinoma-associated molecular markers and their significance in follicular epithelial dysplasia with papillary thyroid carcinoma-like nuclear alterations in Hashimoto's thyroiditis.
Ma H; Yan J; Zhang C; Qin S; Qin L; Liu L; Wang X; Li N
Int J Clin Exp Pathol; 2014; 7(11):7999-8007. PubMed ID: 25550843
[TBL] [Abstract][Full Text] [Related]
16. Total thyroidectomy for the treatment of Hashimoto's thyroiditis coexisting with papillary thyroid carcinoma.
Kurukahvecioglu O; Taneri F; Yüksel O; Aydin A; Tezel E; Onuk E
Adv Ther; 2007; 24(3):510-6. PubMed ID: 17660159
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer.
Wu X; Lun Y; Jiang H; Gang Q; Xin S; Duan Z; Zhang J
Endocrine; 2014 Aug; 46(3):554-60. PubMed ID: 24338678
[TBL] [Abstract][Full Text] [Related]
18. Ultrasonographic findings of papillary thyroid carcinoma with Hashimoto's thyroiditis.
Ohmori N; Miyakawa M; Ohmori K; Takano K
Intern Med; 2007; 46(9):547-50. PubMed ID: 17473486
[TBL] [Abstract][Full Text] [Related]
19. Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.
Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
J Clin Endocrinol Metab; 2012 Jul; 97(7):2380-7. PubMed ID: 22539585
[TBL] [Abstract][Full Text] [Related]
20. Influence of chronic autoimmune thyroiditis and papillary thyroid cancer on serum calcitonin levels.
Rosario PW; Calsolari MR
Thyroid; 2013 Jun; 23(6):671-4. PubMed ID: 23327335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
